Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study
dc.authorwosid | Gumus, Mahmut/HTO-4176-2023 | |
dc.authorwosid | Bilir, Cemil/A-2491-2017 | |
dc.authorwosid | Arslan, Cagatay/I-1932-2016 | |
dc.contributor.author | Arslan, C. | |
dc.contributor.author | Kefeli, U. | |
dc.contributor.author | Yildirim, E. | |
dc.contributor.author | Isikdogan, A. | |
dc.contributor.author | Karadurmus, N. | |
dc.contributor.author | Karabulut, B. | |
dc.contributor.author | Cicin, I. | |
dc.date.accessioned | 2024-08-04T21:00:58Z | |
dc.date.available | 2024-08-04T21:00:58Z | |
dc.date.issued | 2021 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 23rd ESMO World Congress on Gastrointestinal Cance -- JUN 30-JUL 03, 2021 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | ESMO | en_US |
dc.description.sponsorship | Amgen Pharmaceuticals | en_US |
dc.description.sponsorship | This project was funded by Amgen Pharmaceuticals. | en_US |
dc.identifier.doi | 10.1016/j.annonc.2021.05.273 | |
dc.identifier.endpage | S174 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.startpage | S174 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.05.273 | |
dc.identifier.uri | https://hdl.handle.net/11616/103983 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000670004200217 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Annals of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Real-life experience with chemotherapy plus biologics in first-line treatment of right-sided, RAS wild-type, metastatic colon cancer: A multicenter Onco-Colon Turkey study | en_US |
dc.type | Conference Object | en_US |